Consejo Superior de Investigaciones Científicas

Modulating compounds of KChIP2 and its use for the treatment of cardiovascular

Posted by Consejo Superior de Investigaciones CientíficasResponsive · Patents for licensing · Spain

Summary of the technology

ppaatthhoollooggiieess

CSIC and UAM have developed compounds that positively modulate protein-protein interactions that
involve KChIP2 protein.

Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent
licence agreement
An offer for Patent Licensing

Consejo Superior de Investigaciones Científicas
Consejo Superior de Investigaciones Científicas

Modulation of Ito in different cardiac pathologies

Modeling of a potential interaction between the new compounds and KChIP proteins using annealing molecular dynamics analysis.
KChIP2 is a neuronal calcium sensor that regulates voltage-dependent potassium channels, mainly those belonging to the KV4 family, thus generating the outward potassium current (Ito). This current is essential to control cardiac excitability and is reduced in cardiac pathologies.
Various heart diseases, such as cardiac hypertrophy, present a decreased Ito.
Moreover, it has been described that mice lacking KChIP2 are more susceptible to generate ventricular arrhythmias.

Main innovations and advantages


· These compounds have the capacity to modulate KChIP2 function and toaffect the transient outward K+ current in cardiomyocytes. They producea significant increase in the maximum peak current of the outwardpotassium current of cardiomyocytes without modifying the decay timeconstant.
· Taking into account that the down-regulation of KChIP2 is associatedwith the onset of various heart diseases and that the up-regulation ofKChIP2 prevents the development of cardiac hypertrophy in animalmodels, the compounds of the invention, which act as modulators of thisprotein, are potentially useful in the treatment of heart diseasespresenting a decrease in the transient outward K+ current (cardiachypertrophy, arrhythmias, infarct and ischemic failure).

Intellectual property status

Granted Patent
-
Priority patent application filed suitable for international extension

Granted Patent
-
Priority patent application filed suitable for international extension

Technology Owner

Consejo Superior de Investigaciones Científicas

Public Agency

Related keywords

  • Biological Sciences
  • Medicine, Human Health
  • Medical Biomaterials
  • Genetic Engineering / Molecular Biology
  • Microbiology Market
  • Medical Health related
  • Diagnostic
  • Therapeutic
  • Cardiology
  • compounds
  • kchip2

About Consejo Superior de Investigaciones Científicas

Public Agency from Spain

The Spanish National Research Council (in Spanish 'Consejo Superior de Investigaciones Científicas (CSIC)') is a government agency for basic and applied scientific research.

It is the largest public research organization in Spain, with presence in all the Autonomous Communities through 126 centers and 145 associated units.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.